Article

Purwati, Purwati and BUDIONO, 079615333 and BRIAN EKA RACHMAN, NIM011180226 and Yulistiani, Dra. and Andang Miatmoko, Andang Miatmoko and Nasronudin, Dr. dr., Sp.PD-KPTI and Soroy Lardo, Soroy Lardo and Yongki Iswandi Purnama, Yongki Iswandi Purnama and Mafidhatul Laely, Mafidhatul Laely and Ike Rochmad, Ike Rochmad and Taufik Ismail, Taufik Ismail and Sri Wulandari, Sri Wulandari and Dwi Setyawan, Dwi Setyawan and Alfian Nur Rosyid, Alfian Nur Rosyid and Herley Windo Setiawan, Herley Windo Setiawan and Prastuti Asta Wulaningrum, Prastuti Asta Wulaningrum and Tri Pudy Asmarawati, Asmarawati and ErikaMarfiani, ErikaMarfiani and ShintaKarinaYuniati, ShintaKarinaYuniati and MuhammadRabiulFuadi, MuhammadRabiulFuadi and PepyDwiEndraswari, PepyDwiEndraswari and Purwaningsih, Purwaningsih and Eryk Hendrianto, Eryk Hendrianto and Deya Karsari, Deya Karsari and Aristika Dinaryanti, Aristika Dinaryanti and Nora Ertanti, Nora Ertanti and Igo Syaiful Ihsan, Igo Syaiful Ihsan and Disca Sandyakala Purnama, Disca Sandyakala Purnama and Yuni Indrayani, Yuni Indrayani (2021) A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections. HINDAWI. ISSN eISSN: 2314-6141 / pISSN: 2314-6133

Purwati, PURWATI and Andang Miatmoko, Andang Miatmoko and Nasronudin, Nasronudin and Eryk Hendrianto, Eryk Hendranto and Deya Karsari, Deya Karsari and ARISTIKA DINAR YANTI, 060710272 and Nora Ertanti, nora and Igo Syaiful Ihsan, igo and DISCA SANDYAKALA PURNAMA, 081117039 and Tri Pudy Asmarawati, Tri and ERIKA MARFIANI, NIM010980238 and Yulistiani, - and Alfian Nur Rosyid, alfian and Prastuti Asta Wulaningrum, prastuti and Herley Windo Setiawan, herley and IMAM SISWANTO, 088710445 and Ni Nyoman Tri Puspaningsih, Prof. Dr., Dra., M.Si (2020) An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia. PLOS ONE. ISSN 1932-6203